FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036764488> ?p ?o ?g. }

• W2036764488 endingPage "761" @default.
• W2036764488 startingPage "753" @default.
• W2036764488 abstract "This was the first controlled continuation phase study (up to 1-year total treatment) to evaluate the safety and efficacy of bupropion SR for decreasing the risk for relapse of depression in patients who responded to bupropion SR.Patients with recurrent major depression were treated with bupropion SR 300 mg/day during an 8-week open-label phase. Responders (based on Clinical Global Impressions Scale for Improvement of Illness scores) entered a randomized, double-blind phase where they received bupropion SR 300 mg/day or placebo for up to 44 weeks. After randomization, relapse was defined as the point at which the investigator intervened by withdrawing the patient from the study to treat depression.Four hundred twenty-three patients were randomized. A statistically significant difference in favor of bupropion SR over placebo was seen in the time to treatment intervention for depression when survival curves were compared (log-rank test, p =.003). Statistically significant separation between bupropion SR and placebo began at double-blind week 12 (p <.05). Adverse events in bupropion SR-treated patients accounted for 9% and 4% of discontinuations from the open-label and double-blind phases, respectively.Bupropion SR was shown to be effective and well tolerated in decreasing the risk for relapse of depression for up to 44 weeks." @default.
• W2036764488 created "2016-06-24" @default.
• W2036764488 creator A5006447658 @default.
• W2036764488 creator A5014230663 @default.
• W2036764488 creator A5035325770 @default.
• W2036764488 creator A5035853275 @default.
• W2036764488 creator A5036953996 @default.
• W2036764488 creator A5047426652 @default.
• W2036764488 creator A5066621816 @default.
• W2036764488 date "2002-05-01" @default.
• W2036764488 modified "2023-10-15" @default.
• W2036764488 title "Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression" @default.
• W2036764488 cites W168553657 @default.
• W2036764488 cites W1759860330 @default.
• W2036764488 cites W1968012627 @default.
• W2036764488 cites W1970278663 @default.
• W2036764488 cites W1984541748 @default.
• W2036764488 cites W2008979600 @default.
• W2036764488 cites W2018434620 @default.
• W2036764488 cites W2024862901 @default.
• W2036764488 cites W2026326360 @default.
• W2036764488 cites W2032149427 @default.
• W2036764488 cites W2034224601 @default.
• W2036764488 cites W2038225674 @default.
• W2036764488 cites W2045224806 @default.
• W2036764488 cites W2055052693 @default.
• W2036764488 cites W2061378977 @default.
• W2036764488 cites W2072962598 @default.
• W2036764488 cites W2080593090 @default.
• W2036764488 cites W2081948258 @default.
• W2036764488 cites W2089648538 @default.
• W2036764488 cites W2096527989 @default.
• W2036764488 cites W2100495048 @default.
• W2036764488 cites W2108061862 @default.
• W2036764488 cites W2114613490 @default.
• W2036764488 cites W2145911019 @default.
• W2036764488 cites W2160070901 @default.
• W2036764488 cites W2396494208 @default.
• W2036764488 cites W4245161992 @default.
• W2036764488 cites W4247135947 @default.
• W2036764488 cites W428598680 @default.
• W2036764488 cites W54798487 @default.
• W2036764488 doi "https://doi.org/10.1016/s0006-3223(01)01317-8" @default.
• W2036764488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11983189" @default.
• W2036764488 hasPublicationYear "2002" @default.
• W2036764488 type Work @default.
• W2036764488 sameAs 2036764488 @default.
• W2036764488 citedByCount "60" @default.
• W2036764488 countsByYear W20367644882012 @default.
• W2036764488 countsByYear W20367644882015 @default.
• W2036764488 countsByYear W20367644882016 @default.
• W2036764488 countsByYear W20367644882017 @default.
• W2036764488 countsByYear W20367644882018 @default.
• W2036764488 countsByYear W20367644882020 @default.
• W2036764488 countsByYear W20367644882022 @default.
• W2036764488 countsByYear W20367644882023 @default.
• W2036764488 crossrefType "journal-article" @default.
• W2036764488 hasAuthorship W2036764488A5006447658 @default.
• W2036764488 hasAuthorship W2036764488A5014230663 @default.
• W2036764488 hasAuthorship W2036764488A5035325770 @default.
• W2036764488 hasAuthorship W2036764488A5035853275 @default.
• W2036764488 hasAuthorship W2036764488A5036953996 @default.
• W2036764488 hasAuthorship W2036764488A5047426652 @default.
• W2036764488 hasAuthorship W2036764488A5066621816 @default.
• W2036764488 hasConcept C118552586 @default.
• W2036764488 hasConcept C126322002 @default.
• W2036764488 hasConcept C139719470 @default.
• W2036764488 hasConcept C142724271 @default.
• W2036764488 hasConcept C162324750 @default.
• W2036764488 hasConcept C168563851 @default.
• W2036764488 hasConcept C197934379 @default.
• W2036764488 hasConcept C204243189 @default.
• W2036764488 hasConcept C204787440 @default.
• W2036764488 hasConcept C27081682 @default.
• W2036764488 hasConcept C2776867660 @default.
• W2036764488 hasConcept C2777843972 @default.
• W2036764488 hasConcept C2779144063 @default.
• W2036764488 hasConcept C2779908668 @default.
• W2036764488 hasConcept C2780051608 @default.
• W2036764488 hasConcept C2781089641 @default.
• W2036764488 hasConcept C71924100 @default.
• W2036764488 hasConceptScore W2036764488C118552586 @default.
• W2036764488 hasConceptScore W2036764488C126322002 @default.
• W2036764488 hasConceptScore W2036764488C139719470 @default.
• W2036764488 hasConceptScore W2036764488C142724271 @default.
• W2036764488 hasConceptScore W2036764488C162324750 @default.
• W2036764488 hasConceptScore W2036764488C168563851 @default.
• W2036764488 hasConceptScore W2036764488C197934379 @default.
• W2036764488 hasConceptScore W2036764488C204243189 @default.
• W2036764488 hasConceptScore W2036764488C204787440 @default.
• W2036764488 hasConceptScore W2036764488C27081682 @default.
• W2036764488 hasConceptScore W2036764488C2776867660 @default.
• W2036764488 hasConceptScore W2036764488C2777843972 @default.
• W2036764488 hasConceptScore W2036764488C2779144063 @default.
• W2036764488 hasConceptScore W2036764488C2779908668 @default.
• W2036764488 hasConceptScore W2036764488C2780051608 @default.
• W2036764488 hasConceptScore W2036764488C2781089641 @default.
• W2036764488 hasConceptScore W2036764488C71924100 @default.

• next